AnaptysBio is a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology.
AnaptysBio Announces Pricing of Public Offering Thu, 12 Oct 2017 22:45:00 +0000 SAN DIEGO, Oct. 12, 2017-- AnaptysBio, Inc., a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced ...
AnaptysBio Files Registration Statement for Proposed Public Offering Tue, 10 Oct 2017 20:20:00 +0000 SAN DIEGO, Oct. 10, 2017-- AnaptysBio, Inc., a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced ...
ETFs with exposure to AnaptysBio, Inc. : October 2, 2017 Mon, 02 Oct 2017 14:40:04 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AnaptysBio, Inc. Here are 5 ETFs with the largest exposure to ANAB-US. Comparing the performance and risk of AnaptysBio, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
ETFs with exposure to AnaptysBio, Inc. : September 22, 2017 Fri, 22 Sep 2017 14:15:42 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AnaptysBio, Inc. Here are 5 ETFs with the largest exposure to ANAB-US. Comparing the performance and risk of AnaptysBio, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.